Elevated circulating platelet-derived extracellular vesicles (EVs) have been reported in
conditions associated with thrombotic risk. The present study aimed to assess the …

Background Extracellular vesicles (EVs) are submicron membrane-bound vesicles released
from various cells, which are emerging as a potential novel biomarker in cardiovascular …

Arterial thrombosis is a major and global cause of human death and disability. Considering
the socioeconomic costs of arterial thrombosis, identification of biomarkers to predict and …

Elevated circulating platelet-derived extracellular vesicles (pEVs) have been associated with
arterial hypertension. The role of hypertension-mediated organ damage (HMOD) to induce …

Abstract Background Extracellular vesicles (EVs), in particular those derived from activated
platelets, are associated with a risk of future venous thromboembolism. Objectives To study …

Background Extracellular vesicles (EVs), shed in response to cell activation, stress, or injury,
are increased in the blood of patients with cardiovascular disease. EVs are characterized by …

Background: Platelet “Microvesicles”(MVs) are studied for their role in blood coagulation and
inflammation. The study aimed to establish if MVs are related to age, plasma levels of …

Extracellular vesicles (EVs) participate in thrombosis via the functions of molecule
expression on their surfaces, including tissue factor (TF) and phosphatidylserine (PS). TF is …

Introduction Patients with glioma (GM) are at a high risk of venous thromboembolism (VTE).
The role of microvesiculation in the cancer-associated thrombosis mechanisms has been …

Abstract Background Microvesicles (MVs) are small double‐membrane encapsulated
particles shed from cells. Case‐control studies have reported elevated plasma levels of …